- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/115 - Paramyxoviridae, e.g. parainfluenza virus
Patent holdings for IPC class C07K 14/115
Total number of patents in this class: 152
10-year publication summary
|
6
|
5
|
2
|
9
|
4
|
4
|
13
|
12
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10830 |
6 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 381 |
6 |
| University of Georgia Research Foundation, Inc. | 1061 |
6 |
| Boehringer Ingelheim Vetmedica GmbH | 1279 |
5 |
| Institute for Research in Biomedicine | 101 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2958 |
5 |
| Board of Regents, The University of Texas System | 6028 |
4 |
| Janssen Vaccines & Prevention B.V. | 294 |
4 |
| Zoetis Services LLC | 1528 |
4 |
| Pfizer Inc. | 3377 |
3 |
| Les Hospices Civils de Lyon | 3 |
3 |
| Universite Claude Bernard Lyon 1 | 1065 |
3 |
| KM Biologics Co., Ltd | 96 |
3 |
| Icosavax, Inc. | 41 |
3 |
| Glaxosmithkline Biologicals S.A. | 1618 |
2 |
| Biocomo Inc. | 9 |
2 |
| Crucell Holland B.V. | 85 |
2 |
| Dynavax Technologies Corporation | 118 |
2 |
| Icahn School of Medicine at Mount Sinai | 992 |
2 |
| ID Biomedical Corporation of Quebec | 18 |
2 |
| Other owners | 80 |